>
The Decline Of Boys Participating In Youth Sports Has Led To A Generation Of Soft...
First Arrests Hint At How Billions In California Homeless Dollars Vanished...
Trump Refiles $15 Billion Defamation Lawsuit Against New York Times After Court Dismissal
Can Diet-Changes Really Transform ADHD? One Family's Remarkable Discovery
3D Printed Aluminum Alloy Sets Strength Record on Path to Lighter Aircraft Systems
Big Brother just got an upgrade.
SEMI-NEWS/SEMI-SATIRE: October 12, 2025 Edition
Stem Cell Breakthrough for People with Parkinson's
Linux Will Work For You. Time to Dump Windows 10. And Don't Bother with Windows 11
XAI Using $18 Billion to Get 300,000 More Nvidia B200 Chips
Immortal Monkeys? Not Quite, But Scientists Just Reversed Aging With 'Super' Stem Cells
ICE To Buy Tool That Tracks Locations Of Hundreds Of Millions Of Phones Every Day
Yixiang 16kWh Battery For $1,920!? New Design!
Find a COMPATIBLE Linux Computer for $200+: Roadmap to Linux. Part 1
The technique could be a boon for regenerative medicine to treat neurological disorders.
Inflammation is the body's natural response to injury and damage, swelling up to allow better blood flow to the area. It also acts like a "fire alarm" to attract the attention of the immune system to help the healing process, and stem cells are some of the most important responders.
In theory, inflammation could be used to lure these regenerative stem cells to injuries, but of course there are risks. Chronic inflammation underlies conditions like arthritis, multiple sclerosis and Crohn's disease, and has even been linked to cardiovascular diseases, Alzheimer's and depression.
So for the new study, the researchers investigated ways to summon stem cells using inflammation signals without creating further inflammation. The team modified an inflammatory molecule called CXCL12, which had previously been identified as a stem cell attractor. They found that it contains two "pockets" – one that binds to stem cells and one for inflammatory signaling – so they developed a drug that maximizes the binding but minimizes the signaling.
The end result is a drug they call SDV1a, which is designed to be injected almost anywhere in the body to lure stem cells there to begin healing an injury, without causing inflammation.